Northern Trust’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Sell
54,587
-236,609
-81% -$6.55M ﹤0.01% 3159
2025
Q1
$6.47M Buy
291,196
+7,597
+3% +$169K ﹤0.01% 2285
2024
Q4
$5.61M Buy
283,599
+28,393
+11% +$562K ﹤0.01% 2444
2024
Q3
$6.38M Sell
255,206
-37,727
-13% -$943K ﹤0.01% 2342
2024
Q2
$5.47M Buy
292,933
+2,289
+0.8% +$42.7K ﹤0.01% 2345
2024
Q1
$5.73M Sell
290,644
-9,480
-3% -$187K ﹤0.01% 2371
2023
Q4
$5.26M Buy
300,124
+4,005
+1% +$70.2K ﹤0.01% 2484
2023
Q3
$5.14M Buy
296,119
+7,842
+3% +$136K ﹤0.01% 2423
2023
Q2
$4.06M Sell
288,277
-3,843
-1% -$54.1K ﹤0.01% 2614
2023
Q1
$3.14M Buy
292,120
+5,445
+2% +$58.6K ﹤0.01% 2729
2022
Q4
$4.29M Buy
286,675
+15,241
+6% +$228K ﹤0.01% 2578
2022
Q3
$3.49M Sell
271,434
-3,871
-1% -$49.7K ﹤0.01% 2707
2022
Q2
$2.67M Buy
275,305
+7,260
+3% +$70.3K ﹤0.01% 2895
2022
Q1
$2.66M Sell
268,045
-12,587
-4% -$125K ﹤0.01% 2950
2021
Q4
$3.3M Buy
280,632
+6,074
+2% +$71.5K ﹤0.01% 2957
2021
Q3
$3.13M Sell
274,558
-11,640
-4% -$133K ﹤0.01% 3035
2021
Q2
$3.99M Sell
286,198
-13,117
-4% -$183K ﹤0.01% 2977
2021
Q1
$5.54M Sell
299,315
-13,687
-4% -$253K ﹤0.01% 2685
2020
Q4
$5.53M Sell
313,002
-1,410
-0.4% -$24.9K ﹤0.01% 2631
2020
Q3
$4.82M Buy
314,412
+77,402
+33% +$1.19M ﹤0.01% 2553
2020
Q2
$6.04M Buy
237,010
+60,794
+34% +$1.55M ﹤0.01% 2403
2020
Q1
$2.73M Buy
176,216
+28,008
+19% +$433K ﹤0.01% 2670
2019
Q4
$1.64M Sell
148,208
-15,305
-9% -$169K ﹤0.01% 3228
2019
Q3
$1.39M Buy
163,513
+8,614
+6% +$73.3K ﹤0.01% 3276
2019
Q2
$2.1M Buy
154,899
+22,645
+17% +$307K ﹤0.01% 3053
2019
Q1
$2.39M Buy
132,254
+53,670
+68% +$969K ﹤0.01% 2965
2018
Q4
$2.21M Sell
78,584
-358
-0.5% -$10.1K ﹤0.01% 2992
2018
Q3
$2.01M Buy
+78,942
New +$2.01M ﹤0.01% 3210